This Solicitation opportunity from Department Of Defense was posted on June 3, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
SUMATRIPTAN SUCCINA
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract pertains to the procurement of Sumatriptan Succinate, identified by the national stock number 6505-01-374-5874, under purchase request 7017022148 for a quantity of one. The solicitation, numbered SPE2DP-26-T-3666, was posted on June 3, 2026, with a response deadline of June 9, 2026. This solicitation is issued by the Defense Logistics Agency, a component of the Department of Defense, reflecting a federal acquisition effort. Details such as the type of set-aside and NAICS code are not specified, indicating the contract may be open without special socioeconomic designations. The place of performance and specific office address details are not provided. The solicitation is accessible through the Defense Logistics Agency’s procurement portal, which facilitates the submission and review of bids. This procurement seeks to secure this specific pharmaceutical item for defense-related purposes within a tight response timeframe.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
